Robinson, L.A.; Cavanah, A.M.; Lennon, S.; Mattingly, M.L.; Anglin, D.A.; Boersma, M.D.; Roberts, M.D.; Frugé, A.D.
Lactase-Treated A2 Milk as a Feasible Conventional Milk Alternative: Results of a Randomized Controlled Crossover Trial to Assess Tolerance, Gastrointestinal Distress, and Preference for Milks Varying in Casein Types and Lactose Content. Nutrients 2025, 17, 1946.
https://doi.org/10.3390/nu17121946
AMA Style
Robinson LA, Cavanah AM, Lennon S, Mattingly ML, Anglin DA, Boersma MD, Roberts MD, Frugé AD.
Lactase-Treated A2 Milk as a Feasible Conventional Milk Alternative: Results of a Randomized Controlled Crossover Trial to Assess Tolerance, Gastrointestinal Distress, and Preference for Milks Varying in Casein Types and Lactose Content. Nutrients. 2025; 17(12):1946.
https://doi.org/10.3390/nu17121946
Chicago/Turabian Style
Robinson, Laura A., Aidan M. Cavanah, Sarah Lennon, Madison L. Mattingly, Derick A. Anglin, Melissa D. Boersma, Michael D. Roberts, and Andrew Dandridge Frugé.
2025. "Lactase-Treated A2 Milk as a Feasible Conventional Milk Alternative: Results of a Randomized Controlled Crossover Trial to Assess Tolerance, Gastrointestinal Distress, and Preference for Milks Varying in Casein Types and Lactose Content" Nutrients 17, no. 12: 1946.
https://doi.org/10.3390/nu17121946
APA Style
Robinson, L. A., Cavanah, A. M., Lennon, S., Mattingly, M. L., Anglin, D. A., Boersma, M. D., Roberts, M. D., & Frugé, A. D.
(2025). Lactase-Treated A2 Milk as a Feasible Conventional Milk Alternative: Results of a Randomized Controlled Crossover Trial to Assess Tolerance, Gastrointestinal Distress, and Preference for Milks Varying in Casein Types and Lactose Content. Nutrients, 17(12), 1946.
https://doi.org/10.3390/nu17121946
